GF Fund Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.5K Sell
1,561
-118
-7% -$2.7K ﹤0.01% 435
2026
Q1
$39.1K Buy
1,679
+212
+14% +$4.57K ﹤0.01% 427
2025
Q4
$29.3K Buy
1,467
+111
+8% +$2.17K ﹤0.01% 460
2025
Q3
$24.7K Sell
1,356
-246
-15% -$4.8K ﹤0.01% 468
2025
Q2
$32.2K Hold
1,602
﹤0.01% 451
2025
Q1
$29K Buy
1,602
+288
+22% +$5.16K ﹤0.01% 465
2024
Q4
$22.8K Buy
+1,314
New +$25.2K ﹤0.01% 462

Other funds holding INVA

GF Fund Management's INVA Position: Q2 2026 in Review

GF Fund Management reduced its Innoviva (INVA) stake by 7% in Q2 2026, selling an estimated $2.7K and leaving 1,561 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #435.

GF Fund Management first reported a position in INVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $39.1K in Q1 2026. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • GF Fund Management held 1,561 shares of Innoviva worth $35.5K as of Q2 2026.
  • GF Fund Management sold 118 Innoviva shares in Q2 2026, an estimated $2.7K.
  • Innoviva made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #435 holding.
  • GF Fund Management first reported a position in Innoviva in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Innoviva position peaked at $39.1K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.